LIDDS: Licensavtal med kinesisk partner

Research Note

2018-05-16

15:27

LIDDS har skrivit ett licensieringsavtal rörande Liproca Depot med det kinesiska farmabolaget Jiangsu Ambition Medical.

MS

Mathias Spinnars

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.